A cluster of multiple sclerosis cases in Lysvik in the Swedish county of Värmland

Acta Neurologica Scandinavica

Volumn 110, Issue 1, 2004, Pages 14-22

  Callander, M ^a   Landtblom, A M ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cluster; Finnish ancestry; Multiple sclerosis

Indexed keywords

CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC DISORDER; HEALTH SURVEY; HUMAN; MALE; MULTIPLE SCLEROSIS; PREVALENCE; REVIEW; SWEDEN;

CLUSTER ANALYSIS; CONSANGUINITY; EMIGRATION AND IMMIGRATION; FEMALE; FINLAND; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MORTALITY; MULTIPLE SCLEROSIS; PEDIGREE; PREVALENCE; SWEDEN;

EID: 3042696525     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2004.00266.x     Document Type: Review

References (57)

1. SADOVNICK AD, EBERS GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993;20:17-29.
2. JERSILD C, FOG T, HANSEN GS et al. Histocompability determinats in multiple sclerosis, with special reference to clinical course. Lancet 1973;2:1221-5.
3. HILLERT J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994;36(Suppl.):S15-17.
4. COMPSTON A. Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:553-61.
5. ALLEN M, SANDBERG-WOLLHEIM M, SJOGREN K, ERLICH HA, PETTERSON U, GYLLENSTEN U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994;39:41-48.
6. BARCELLOS LF, THOMSON G, CARRINGTON M, SCHAFER J, BEGOVICH AB, LIN P et al. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of new susceptibility locus in caucasian and Chinese patients. JAMA 1997;278:1256-61.
7. OLSSON JE, MÖLLER E, LINK H. HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol 1976;33:808-12.
8. PERICAK-VANCE MA, RIMMLER JB, MARTIN ER, HAINES JL, GARCIA ME, OKSENBERG JR et al. A detailed examination of chromosome 19q13 in multiple sclerosis using linkage and association analysis. Neurogenetics 2001;3:195-201.
9. OKSENBERG JR, BARANZINI SE, BARCELLOS LF, HAUSER SL. Multiple sclerosis. Genomic rewards (Review). J Neuroimmunol 2001;113:171-84.
10. SAWCER SJ, GOODFELLOW PN, COMPSTON DAS. The genetic analysis of MS. Trends Genet 1997;3:234-9.
11. HAINES JL, TER-MINASSIAN M, BAZYK A, GUSELLA JF, KIM DJ, TERWEDOW H et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat Genet 1996;13:469-71.
12. EBERS GC, KUKAY K, BULMAN DE, SADOVNICK AD, RICE G, ANDERSON C et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-6.
13. DYMENT DA, WILLER CJ, SCOTT B, ARMSTRONG H, LIGERS A, HILLERT J et al. Genetic susceptibility to MS: a second stage analysis in canadian MS families. Neurogenetics 2001;3:145-51.
14. KUOKKANEN S, GSCHWEND M, RIOUX JD, DALY MJ, TERWILLIGER JD, TIENARI PJ et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. American J of Human Genetics 1997;61:1379-87.
15. POSER MP. The dissemination of multiple sclerosis: a Viking saga? A historical essay. Ann Neurol 1994;36(S2):S231-43.
16. SADOVNICK AD, AMSTRONG H, RICE GP et al. A population based study of multiple sclerosis in twins: update. Ann Neurol 1993;33:281-5.
17. MUMFORD CJ, WOOD NW, KELLAR-WOOD H, THORPE JW, MILLER DH, COMPSTON DAS. The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11-15.
18. EBERS GC, SADOVNICK AD, RISCH NJ, THE CANADIAN COLLABORATIVE STUDY GROUP. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995;377:150-1.
19. SADOVNICK AD, EBERS GC, DYMENT DA, RISCH NJ, The Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. Lancet 1996;347:1728-30.
20. SADOVNICK AD, BAIRD PA, WARD RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533-41.
21. ROBERTSON NP, FRASER M, DEANS J, CLAYTON D, WALKER N, COMPTSON DAS. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996;119:449-55.
22. ROBERTSON NP, O'RIORDAN JI, CHATAWAY J et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997;349:1587-90.
23. RIISE T. Cluster studies in multiple sclerosis. Neurology 1997;49:S27-32.
24. KURTZKE JF. A Fennoscandian focus of multiple sclerosis. Neurology 1968;18:16-20.
25. POSER CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994;36(Suppl. 2):180-93.
26. COMPSTON DAS. The epidemiology of multiple sclerosis: principles, achievements and recommendations. Ann Neurol 1994;36(Suppl. 2):211-17.
27. RIISE T, WOLFSON C. The epidemiologic study of exogenous factors in the etiology of multiple sclerosis. Neurology 1997;49(Suppl. 2):15-17.
28. GRANIERI E. The epidemiologic study of exogenous factors in the etiology of multiple sclerosis: introduction. Neurology 1997;49(Suppl. 2):1-3.
29. ALTER M, KAHANA E, LOEWENSON R. Migration and risk of multiple sclerosis. Neurology 1978;28:1089-93.
30. DEAN G, KURZKE JF. On the risk of MS according to age at immigration to South Africa. Br Med J 1971;3:725-29.
31. KURTZKE JP. Geography in multiple sclerosis. J Neurol 1977;215:1-26.
32. LAUER K. Multiple sclerosis in the old world: the new old map. In: Firnhaber W, Lauer K, eds. Multiple sclerosis in Europe. An epidemiological update. Alsbach/Bergstrasse: LTV Press, 1994;13-27.
33. WIKSTRÖM J, TIENARI PJ, SUMELAHTI ML, HOVI E, KINNUNEN E, PALO J. Multiple sclerosis in Finland: evidence of uneven geographic distribution, increasing frequency and high familial occurrence. In: FIRNHABER W, LAUER K, eds. Multiple sclerosis in Europe. An epidemiological update. Leuchtturm-Verlag: LTV Press, 1994;73-78.
34. ROTHWELL PM, CHARLTON D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of genetic predisposition. J Neurol Neurosurg Psychiatry 1998;64:730-5.
35. SWINGLER R, COMPSTON D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986;49:1115-24.
36. BENEDIKZ J, MAGNÚSSON H, GUMUNDSSON G. Multiple sclerosis in Iceland, with observation on the alleged epidemic in the Faoe Islands. Ann Neurol 1994;36(S2):S175-79.
37. WYNN P, RODRIQUEZ M, O'FALLON W, KURLAND L. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990;40:780-6.
38. WARREN S, WARREN KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993;43:1760-3.
39. MILLER D, HAMMOND S, MCLEOD J et al. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry 1990; 53:903-5.
40. KURTZKE JF. Further features of the fennoscandinavian focus of multiple sclerosis. Acta Neurol Scand 1974;50: 478-502.
41. KURTZKE JF. Multiple sclerosis epidemiology world wide: one view of current status. Acta Neurol Scand 1995;161(Suppl.):23-33.
42. KOCH-HENRIKSEN N. Multiple sclerosis in Scandinavian and Finland. Acta Neurol Scand 1995;91(Suppl.):55-59.
43. Compston DAS. Distribution of multiple sclerosis. In: COMPSTON DAS, EBERS G, LASSMAN H, MCDONALD I, MATTHEWS B, WEKERLE H, eds. McAlpine multiple sclerosis. 3rd edn. London: Churchill Livingstone, 1998;63-100.
44. PIHLAJA H, RANTAMÄKI T, WIKSTRÖM J et al. Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to genetically defined subpopulation in Finland. Genes Immun 2003;4:138-46.
45. SUMELAHTI M-L, TIENARI PJ, WIKSTRÖM J, PALO J, HAKAMA M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand 2001;103:153-8.
46. BINZER M, FORSGREN L, HOLMGREN G, DRUGGE U, FREDRIKSON S. Familial clustering of multiple sclerosis in a northern Swedish rural district. J Neurol Neurosurg Psychiatry 1994;57:497-9.
47. HADER WJ, IRVINE DG, SCHIEFER HB. A cluster-focus of multiple sclerosis at Henribourg, Saskatchewan. Can J Neurol Sci 1990;17:391-4.
48. HELMICK CG, WRIGLEY JM, ZACK MM et al. Multiple sclerosis in Key West, Florida. Am J Epidemiol 1989;5:935-49.
49. SVENNINGSSON A, RUNMARKER B, LYCKE J, ANDERSEN O. Incidence of MS during two fifteen-year periods in the Gothenburg region in Sweden. Acta Neurol Scand 1990; 82:161-8.
50. SUNDSTRÖM P, NYSTRÖM L, FORSGREN L. Prevalence of multiple sclerosis in Västerbotten county in northern Sweden. Acta Neurol Scand 2001;103:214-18.
51. LANDTBLOM AM, BOIKO A, SÖDERFELDT B, RIISE T. The distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics. Neuroepidemiology 2002;21:167-79.
52. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
53. KURTZKE J.F. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444.
54. LINDQVIST H. Historien om Sverige. När riket sprängdes och bernadotte blev kung. Stockholm: Norsteds Förlag, 1998.
55. Search motor: HUB, http://www.webring.com/hub7ring= historiaringen. Finnarna: en bricka i stormakternas spel.
56. RINNE UK, PANELIUS M, KIVALO E, HOKKANEN E, PALO J. Distribution of multiple sclerosis in Finland with special reference to some geological factors. Acta Neurol Scand 1966;42:385-99.
57. GIEDRAITIS V, MODIN H, CALLANDER M et al. Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. Genes Immun 2003;4:559-63.